TCS Digital AI

AI in Pharmacovigilance — Re-imagining the ICSR processing

Over the last few decades, we have seen a spurt of medicines approved by regulatory authorities which have necessitated an increase in the need for monitoring drugs. Pharmacovigilance, is an arm of medical science which deals with gathering, monitoring and assessing the safety of drugs. It has gained increased focus and prominence, over the last decade. It’s thus not a …

Re-Imagining Drug Safety Powered by Genomics, Information Integration and Emerging Technologies

|| Whitepaper by Tata Consultancy Services. Pub. 17/08/2017 Abstract Scientific advancements, emerging technologies, and extensive information have created new opportunities for modernizing drug safety.  Simultaneously, the pharmacovigilance regulatory landscape is shifting to ensure improved safety for patients. This is the time to reimagine the  drug safety sector to transform it into an advanced, proactive and patient-centric practice. Introduction The global …

Rising costs may not be a result of orphan drugs

Published Online: Sep 12,2016 Laurie Toich, Assistant Editor From Daraprim’s price rising 5556% by Turing Pharmaceuticals under the leadership of Martin Shkreli, to the most recent pricing scandal with Mylan’s EpiPen, Americans have been faced with high out-of-pocket costs for many prescription drugs. Government institutions, such as the US Centers for Medicare and Medicaid, have begun crafting novel ways to reduce …

Interview: Veterans Affairs Precision Oncology Project

Our supporting partner DNAdigest got in touch with one of our speakers at BioData World Congress– Louis Fiore, doctor, scientist, manager, innovator at the Department of Veterans Affairs (VA) in Boston Massachusetts, Executive Director of the Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC). Louis will be speaking about the Precision Oncology Project at BioData World Congress USA 2016. We want to share some …

Diagnosis in neurosurgery

Remote intra-operative diagnosis in neurosurgery

Graham McHardy CSci FIBMS Department of Pathology, Aberdeen Royal Infirmary, Foresterhill, Aberdeen, UK   The introduction of digital slide scanning for remote reporting has restored an important service for patient healthcare at a Scottish hospital Telepathology is the process of digitising histological images for transmission electronically to remote centres, often for the purposes of diagnosis. Some telepathology systems employ robotic microscopes, which can be controlled remotely in order …

Innovative partnerships to bring health apps into mainstream healthcare and support

Dee O’Sullvan, Director, My health maps and Patient View, investigates in her presentation given at last year’s Pharma Engagement Live event, why health apps are important to patients, healthcare and pharma. Download and learn: The unavoidable logic of health apps How are pharma and HCP’s to respond? Important developments in the health app market Patients want to use apps with …

value, assessment

From promise to reality: how is real world evidence shaping the future of healthcare?

At Evidence EU  2014, David Haslam, Chairman NICE gave a presentation on “From promise to reality: how is real world evidence shaping the future of healthcare?” This presentation explores NICE’s role in improving outcomes for people as well as focusing on challenges (uptake, implementation and pushy patients) and value-based assessment. Download and learn: The multi morbidity challenge Value Based Assessment …

Financial, Forecast, Opportunity, Biosimilar, Medicine, Global, Healthcare, Marketplace

Financial Forecast: Opportunities For Biosimilar Medicines In The Global Healthcare Marketplace

At the Biosimilar Drug Development World Europe event 2014, Ashwin Pai, Jefferies International, gave a presentation on “Financial Forecast: Opportunities For Biosimilar Medicines In The Global Healthcare Marketplace.” Download and learn: Biosimilars – Where Do We Stand Today? What Does The Future Hold? Emerging Markets – Opportunity Large Than Previously Expected Developed Markets – Wide Differences Across Markets And Molecules What …

Value, European, Healthcare, Market

How to develop a compelling value proposition in the current European healthcare market

At Evidence EU 2014, Caroline Gadd, Otsuka Pharmaceuticals, gave a presentation on “How to develop a compelling value proposition in the current European healthcare market”. Gadd’s presentation highlights the importance of value proposition, demonstrating that a successful proposition is moving towards a customer centric approach as well as being able to support the whole market. Download and Learn: The value proposition as …